share_log

Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology

Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology

Rapid Micro Biosystems 宣布发表支持药物微生物学中全自动菌落计数的多作者案例研究
Benzinga Real-time News ·  2022/12/07 16:31

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company, providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, announced the publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology.

亚洲网加利福尼亚州圣何塞10月23日电提供关键任务自动化解决方案以促进保健产品高效制造和快速、安全释放的创新生命科学技术公司Rapid Micro BiosSystems,Inc.(纳斯达克代码:RFID)(以下简称“本公司”)宣布出版了一份多作者案例研究报告,该研究报告支持制药微生物学中的全自动菌落计数。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发